BU-NOT-SET

CONTACT US
What the new Drug Supply Chain Security Act (DSCSA) deadline means for the industry
  • Manufacturing
Eyes
Insight
Serialisation: is the industry ready?
  • Manufacturing
Eyes
Insight
Serialisation efforts must push ahead despite deadline extension
  • Manufacturing
Eyes
Insight
Metal coordinated pharmaceuticals: a new and promising technology
  • Drug product
Eyes
Insight
Optimising excipient selection
  • Drug product
Eyes
Insight
Serialisation stragglers: Industry concern for complacency
  • Manufacturing
Eyes
Insight
The race against the serialisation deadline
  • Manufacturing
Eyes
Insight
Why tomorrow is too late to start your serialisation preparations
  • Manufacturing
Eyes
Insight
The serialisation landscape: Challenges and opportunities for a CDMO
  • Manufacturing
Eyes
Insight
Insight
  • Drug product
Evolving strategies in oral solid dosage development
Case study
  • Sustainability
Sustainable pharmaceutical packaging
Webinar
  • Drug product
  • Manufacturing
Webinar | Bringing High Potent Drugs to Market
White paper
  • Drug product
  • Manufacturing
IVPT Strategies for reliable bioequivalence assessment
White paper
  • Biologics
  • Manufacturing
Recipharm Advanced Bio Is Advancing Optimizing TFF for RNA
Case study
  • Drug product
  • Manufacturing
Accelerating an innovative high potency oncology therapy to market
Insight
  • Manufacturing
When OSD manufacturing goes global
Insight
  • Drug product
  • Manufacturing
Ensuring Reliable HPAPI Supply
Insight
  • Drug product
  • Manufacturing
De-risking high-potency programmes